Skip to main content

Table 5 Multivariate CRC-specific survival analysis of different clinical stages in left-sided and right-sided CRC

From: Analysis of prognosis, genome, microbiome, and microbial metabolome in different sites of colorectal cancer

 

RS

LS

HR (95% CI)

Stage at presentation

 Stage 0

1.00

0.72 (0.6–0.86)**

 Stage I

1.00

0.71 (0.68–0.74)**

 Stage II

1.00

0.74 (0.71–0.76)**

 Stage III

1.00

0.69 (0.67–0.72)**

 Stage IV

1.00

0.72 (0.66–0.78)**

 All stages

1.00

0.71 (0.69–0.72)**

  1. ** p < 0.001, *p < 0.05; CI confidence interval, HR hazard ratio. The classification criteria of stages refer to the AJCC/UICC TNM staging system. Right-sided (RS) CRC includes cancers located in the cecum, ascending colon, and transverse colon, and left-sided (LS) CRC include those located in the descending colon, sigmoid colon, and rectum. The LS group was set to 1 as the control group